[Fracture incidence in 803 women with postmenopausal osteoporosis under drug treatment].
In a survey of cases of confirmed postmenopausal osteoporosis, 803 women were asked to complete a questionnaire on radiologically confirmed fractures sustained prior to and during drug therapy. Under monotherapy (fluoride or calcium, n = 92) the number of peripheral and central fractures was 54% and 49% lower, respectively. The corresponding figures with two substances (fluoride and calcium, n = 226) were 58% and 60%, with three substances (fluoride, calcium and estrogens or Vitamin D, n = 223) 83% and 72%, and with four substances (n = 254) 85% and 75%.
Cronenberg
A
A
Rheumaklinik II, Wiesbaden.
Minkus
A
A
Bremer
G
G
Keck
E
E
D000368:Aged; D002118:Calcium / Q000008:administration & dosage; D004359:Drug Therapy, Combination; D015914:Estrogen Replacement Therapy; D005260:Female; D005459:Fluorides / Q000008:administration & dosage; D050723:Fractures, Bone / Q000453:epidemiology* / Q000209:etiology; D005858:Germany / Q000453:epidemiology; D006801:Humans; D015994:Incidence; D008875:Middle Aged; D015663:Osteoporosis, Postmenopausal / Q000150:complications* / Q000188:drug therapy*; D014807:Vitamin D / Q000008:administration & dosage
D014807:Vitamin D; D005459:Fluorides; D002118:Calcium
Frakturinzidenz unter der medikamentösen Behandlung bei 803 Frauen mit einer Postmenopause-Osteoporose.